Fact checked by Nick Blackmer Zunveyl (benzgalantamine)—a better-tolerated version of the Alzheimer’s drug Razadyne ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

“There are things that we can do at all stages of our lives deliberately,” says Prof Schott. “It’s never too early to start ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...

By 2060, 1 million adults per year will develop dementia, according to a study published in Nature Medicine. Also in the news, chronic cannabis use may lead to chronic illness; Eli Lilly hopes to ...

If you read all ten of these non-fiction titles in the next couple of months, you’d be 67% of the way to the average number ...

We explore the MAHA movement and sobriety, and a shift to 'natural' birth control, while an opinion writer says it's possible ...

Biden took on Big Pharma by capping out-of-pocket drug costs ... There's a new medical group forming in CT. It promises an ...

A bill recently signed into law is shaking up some of the criteria regarding driver’s license suspensions. Governor DeWine ...

The FDA is proposing nutrition information be placed on the front of packaged foods to provide at-a-glance information about saturated fat, sodium and added sugar.

The maker of ChatGPT hopes to spur investment from the Middle East and avoid strict regulations on the development of new technologies. By Cade Metz and Cecilia Kang New rules aim to keep ...